Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Epidemiology and prognostic determinants of bacteremic acute pyelonephritis in women.

Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Pitart C, Mensa J.

J Infect. 2013 Feb;66(2):193-6. doi: 10.1016/j.jinf.2012.10.015. Epub 2012 Oct 17. No abstract available.

PMID:
23085247
2.

Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis.

Lee SS, Kim Y, Chung DR.

J Infect. 2011 Feb;62(2):159-64. doi: 10.1016/j.jinf.2010.10.009. Epub 2010 Nov 3.

PMID:
21055417
3.

Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.

Lim SK, Park IW, Lee WG, Kim HK, Choi YH.

Yonsei Med J. 2012 Jan;53(1):164-71. doi: 10.3349/ymj.2012.53.1.164.

4.

A simple intervention to reduce inappropriate ciprofloxacin prescribing in the emergency department.

Fagan M, Lindbæk M, Reiso H, Berild D.

Scand J Infect Dis. 2014 Jul;46(7):481-5. doi: 10.3109/00365548.2014.880187. Epub 2014 Feb 20.

PMID:
24552583
5.

Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial.

Mombelli G, Pezzoli R, Pinoja-Lutz G, Monotti R, Marone C, Franciolli M.

Arch Intern Med. 1999 Jan 11;159(1):53-8.

PMID:
9892331
6.

Comparative activities of five antimicrobial agents in experimental Proteus pyelonephritis in mice.

Peerbooms PG, Maclaren DM.

Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S30-2.

PMID:
3325927
8.

Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.

Jeon JH, Kim K, Han WD, Song SH, Park KU, Rhee JE, Song KH, Park WB, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB.

Antimicrob Agents Chemother. 2012 Jun;56(6):3043-6. doi: 10.1128/AAC.06212-11. Epub 2012 Mar 5.

9.

Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.

Waugh J, Keating GM.

Drugs Aging. 2004;21(1):55-64; discussion 65-6. Review.

PMID:
14715044
10.

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.

Klausner HA, Brown P, Peterson J, Kaul S, Khashab M, Fisher AC, Kahn JB.

Curr Med Res Opin. 2007 Nov;23(11):2637-45.

PMID:
17880755
11.

Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis: a prospective multicentre study.

Wie SH, Ki M, Kim J, Cho YK, Lim SK, Lee JS, Kwon KT, Lee H, Cheong HJ, Park DW, Ryu SY, Chung MH, Pai H.

Clin Microbiol Infect. 2014 Oct;20(10):O721-9. doi: 10.1111/1469-0691.12500. Epub 2014 Jan 22.

12.

[Ceftriaxone: whether there is future for it?].

Sidorenko SV.

Antibiot Khimioter. 2006;51(8):3-9. Review. Russian. No abstract available.

PMID:
18030778
13.

Study finds surprising amount of bacterial resistance to standard antibiotic treatment of kidney infections.

[No authors listed]

Rep Med Guidel Outcomes Res. 2000 Mar 30;11(7):8-10. No abstract available.

PMID:
11795320
14.

[Current role of aminoglycosides in the treatment of acute pyelonephritis].

Caron F.

Prog Urol. 1998 Dec;8(6):1077-9. Review. French.

PMID:
9894273
15.

Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.

Giamarellos-Bourboulis EJ, Perdios J, Gargalianos P, Kosmidis J, Giamarellou H.

J Postgrad Med. 2003 Apr-Jun;49(2):118-22.

16.

[The effect of intravenous ciprofloxacin for community acquired pneumonia in adults].

Fujita M, Ishibashi T, Hara N, Yoshida M, Yamada H; Fukuoka Respiratory Infection Study Group.

Jpn J Antibiot. 2003 Aug;56(4):289-93. Japanese.

PMID:
14567253
17.

Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.

Carrie AG, Metge CJ, Collins DM, Harding GK, Zhanel GG.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):863-70.

PMID:
15386718
18.

Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.

Bailey RR, Begg EJ, Smith AH, Robson RA, Lynn KL, Chambers ST, Barclay ML, Hornibrook J.

Clin Nephrol. 1996 Sep;46(3):183-6.

PMID:
8879853
19.

Does solely clinical diagnostics lead to overdiagnoses and overtreatments?: Pneumonia in children.

Korppi M.

Pediatr Infect Dis J. 2012 Aug;31(8):885. doi: 10.1097/INF.0b013e31825ac0d3. No abstract available.

PMID:
22801102
20.

Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis.

Bailey RR, Lynn KL, Robson RA, Peddie BA, Smith A.

N Z Med J. 1992 Mar 25;105(930):102-3.

PMID:
1553112
Items per page

Supplemental Content

Write to the Help Desk